New resolution on medicinal products and medical devices in the TTIP

Health technologies

Today, TACD releases a new policy resolution on medicinal products and medical devices (considered as health technologies by WHO) in the Trans-Atlantic Trade and Investment Partnership (TTIP). The resolution offers a set of recommendations to the EU and US negotiators, stressing that TTIP should under no circumstances reinforce the monopoly power of pharmaceutical corporations, limit the freedom …

Read More →

Can we afford our medicines?


On 12 November 2014, the Transatlantic Consumer Dialogue (TACD) together with a number of other NGOs organised the conference “Can we afford our medicines? The access to medicines crunch in Europe”. The event drew a large crowd in the European Parliament and will hopefully be a turning point in the fight for universal access to …

Read More →

New Resolution on Access to Medicines

The Intellectual Property Committee of the Transatlantic Consumer Dialogue (TACD) has adopted a new resolution on access to medicines. In the European Union and in the United States the cost of medicines is creating a growing financial burden for patients and health systems. TACD calls for new and fair incentives for biomedical innovation that promote …

Read More →